Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection-Reference-Cited by-同舟云学术

Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection

Published:2020-02-07 Issue:5 Volume:71 Page:1533-1545
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Murata Kazumoto¹²^ORCID,Tsukuda Senko³⁴,Suizu Futoshi⁵^ORCID,Kimura Akihiro⁶,Sugiyama Masaya²,Watashi Koichi⁴,Noguchi Masayuki⁵,Mizokami Masashi²

Affiliation:

1. Department of Gastroenterology Graduate School of Medical Sciences International University of Health and Welfare Nasushiobara Japan

2. Genome Medical Sciences Project National Center for Global Health and Medicine Ichikawa Japan

3. RIKEN Center for Integrative Medical Sciences (IMS) Wako Japan

4. Department of Virology II National Institute of Infectious Diseases Tokyo Japan

5. Division of Cancer Biology Institute for Genetic Medicine Hokkaido University Sapporo Japan

6. Department of Immunology and Pathology Research Center for Hepatitis and Immunology Research Institute National Center for Global Health and Medicine Ichikawa Japan

Funder

National Center for Global Health and Medicine

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30956

Reference37 articles.

1. Hepatitis B virus infection

2. Present and future therapies of hepatitis B: From discovery to cure

3. Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

4. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

5. Acyclic nucleoside phosphonates: a key class of antiviral drugs

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis;Frontiers in Pharmacology;2024-08-22

2. Comparative evaluation of adverse drug reactions for tenofovir alafenamide and tenofovir disoproxil fumarate using the FAERS Database: a disproportionality analysis;Expert Opinion on Drug Safety;2024-08-19

3. Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy;Journal of the Formosan Medical Association;2024-08

4. Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-07

5. Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma;BMC Cancer;2024-03-04